Localized tenosynovial giant cell tumor in children.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 37799313.
- Also identified by DOI 10.1177/18632521231186795 and PMC identifier 10549694.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To investigate the clinical characteristics and surgical efficacy of localized tenosynovial giant cell tumors in children. The clinical data, surgery, and follow-up results of 17 children with localized tenosynovial giant cell tumors who visited our hospital from 2011 to 2021 were collected for statistical analysis. The median patient age was 7 years and 8 months, and the ratio of males to females was 1.43 (10/7). The predilection of disease was similar in hands and feet, and the common presenting symptom was mass. One patient experienced recurrence after surgery, and one child had postoperative functional limitations. Extremities are common sites of localized tenosynovial giant cell tumors in children. Complete surgical resection helps reduce the recurrence rate. Level III.